Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with no effective treatment. The epithelial-mesenchymal transition (EMT) is a critical stage during the development of fibrosis. To assess the effect of sulforaphane (SFN) on the EMT and fibrosis using an in vitro tra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Pharmacol Toxicol
Autors principals: Kyung, Sun Young, Kim, Dae Young, Yoon, Jin Young, Son, Eun Suk, Kim, Yu Jin, Park, Jeong Woong, Jeong, Sung Hwan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5879815/
https://ncbi.nlm.nih.gov/pubmed/29609658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-018-0204-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars